• A multicenter study on insulin-like growth factor-I serum levels in children with chronic inflammatory diseases
• A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis
• A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis
• Adult seronegative arthritis with antinuclear antibodies: a distinct group of patients with a different immunogenetic pattern from seropositive rheumatoid arthritis and a good outcome
• Anterior uveitis and juvenile idiopathic arthritis
• Application of the new PRINTO classification criteria for juvenile idiopathic arthritis in a sample of Portuguese patients
• Arthritic manifestations in ulcerative colitis
• Assessment of quality of life and physical activity in patients with oligoarticular juvenile idiopathic arthritis in remission
• Assessment of quality of life of parents of children with juvenile chronic arthritis
• Autoantibodies to chromatin: prevalence and clinical significance in juvenile rheumatoid arthritis
• Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE)
• Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
• CCL24, CXCL9 and CXCL10 are increased in synovial fluid in patients with juvenile idiopathic arthritis requiring advanced treatment
• Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan
• Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease
• Correlation between clinical and ultrasound assessment of the knee in children with mono-articular or pauci-articular juvenile rheumatoid arthritis
• Current medication choices in juvenile rheumatoid arthritis II--update of a survey performed in 1993
• Current use of biologicals for the treatment of spondyloarthropathies
• Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis
• Differentially Expressed Inflammation-Regulating MicroRNAs in Oligoarticular Juvenile Idiopathic Arthritis
• Drug treatment in juvenile chronic arthritis
• Effect of methotrexate on the temporomandibular joint and facial morphology in juvenile rheumatoid arthritis patients
• Endocrine autoimmunity in young patients with juvenile chronic arthritis
• Epidemiological study of juvenile idiopathic arthtitis in the last sixteen years in Asturias (Spain)
• Epidemiology of chronic arthritis in childhood
• Etanercept therapy in children with treatment-resistant uveitis
• Evaluation of ILAR classification criteria for juvenile idiopathic arthritis in Spanish children
• Evaluation of revised International League of Associations for Rheumatology classification criteria for juvenile idiopathic arthritis in Spanish children (Edmonton 2001)
• Evidence for immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis
• Extraintestinal Manifestations of Inflammatory Bowel Disease
• Final height, armspan, subischial leg length and body proportions in juvenile chronic arthritis. A long-term follow-up study
• Growth of prepubertal children with juvenile chronic arthritis
• Hepatitis C virus infection and arthritis. A clinico-serological investigation of arthritis in patients with or without cryoglobulinemic syndrome
• Identification of key biomarkers in RF-negative polyarticular and oligoarticular juvenile idiopathic arthritis by bioinformatic analysis
• Identification of Mycoplasma fermentans in synovial fluid samples from arthritis patients with inflammatory disease
• Immunohistochemical study of chronic nongranulomatous anterior uveitis in juvenile idiopathic arthritis
• Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis
• Immunoprinting excludes many potential susceptibility genes as predisposing to early onset pauciarticular juvenile chronic arthritis except HLA class II and TNF
• Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis
• Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease
• Intra-synovial corticosteroid injections in juvenile chronic arthritis--a review
• Intraarticular corticosteroid injection in the management of children with chronic arthritis
• Intraarticular triamcinolone hexacetonide injection in children with chronic arthritis: a survey of clinical practice
• Inverted ratio of m-fas/s-fas expression in early onset pauciarticular juvenile chronic arthritis
• Is tear proteome profile a predictor of developing uveitis in ANA-positive patients with oligoarticular juvenile idiopathic arthritis?
• Juvenile arthritis: genetic update
• Juvenile chronic arthritis and the craniovertebral junction in the paediatric patient: review of the literature and management considerations
• Juvenile chronic arthritis in urban San José, Costa Rica: a 2 year prospective study
• Juvenile chronic arthritis into adulthood: a long-term follow-up study
• Juvenile chronic arthritis profile in Greek children
• Juvenile rheumatoid arthritis in India--rarity of antinuclear antibody and uveitis
• Kre-Celazine(®) as a viable treatment for juvenile rheumatoid arthritis/juvenile idiopathic arthritis - a pilot study
• Low levels of anti-histone antibodies in north Indian children with juvenile rheumatoid arthritis
• Microdissecting Epigenetic Pathways in Oligoarticular Juvenile Idiopathic Arthritis: A New Avenue in Transforming Growth Factor β?
• Minor impact of juvenile arthritis on nutritional status in young adult patients
• Myasthenia gravis in a patient with pauciarticular juvenile chronic arthritis
• Natural autoimmunity in oligoarticular juvenile idiopathic arthritis
• Neutrophils extracellular traps formation may serve as a biomarker for disease activity in oligoarticular juvenile idiopathic arthritis: a pilot study
• Ocular complications and visual outcome in juvenile chronic arthritis: a 25-year follow-up study
• Ocular manifestations in children and adolescents with Lyme arthritis
• Ocular threat in juvenile idiopathic arthritis
• One hundred and seventy cases of childhood-onset rheumatological disease in Singapore
• Orofacial pain, jaw function, and temporomandibular disorders in women with a history of juvenile chronic arthritis or persistent juvenile chronic arthritis
• Pattern of joint involvement in children with Lyme arthritis
• Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register
• Peripheral arthritis in psoriatic arthritis: from immunopathogenesis to therapy with Janus kinase inhibitors
• Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: a real-world data analysis
• Physiotherapy in pauciarticular juvenile idiopathic arthritis. Case study
• Plasma and synovial fluid soluble CD23 concentrations in children with juvenile chronic arthritis
• Predictors of relapse in patients with oligoarticular juvenile idiopathic arthritis in remission off medication
• Preferential immunoglobulin oxidation in children with juvenile idiopathic arthritis
• Pregnancy and early onset pauciarticular juvenile chronic arthritis
• Prevalence of IgM-, IgA- and IgG-rheumatoid factors in seronegative polyarticular disease compared to pauciarticular disease in juvenile chronic arthritis as measured by ELISA
• Prognosis in juvenile arthritis
• Prognostic significance of juvenile chronic arthritis onset types
• Prolactin and interleukin 6 in prepubertal girls with juvenile chronic arthritis
• Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkers
• Recurrent hypopyon in chronic anterior uveitis of pauciarticular juvenile idiopathic arthritis
• Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup
• Review article: joint involvement in inflammatory bowel disease
• Sensitivity and specificity of criteria for spondyloarthritis in children with late onset pauciarticular juvenile chronic arthritis as well as their characteristics
• Serum interleukin 12 concentration in juvenile chronic arthritis
• Serum soluble CD23 levels and CD23 expression on peripheral blood mononuclear cells in juvenile chronic arthritis
• Soluble intercellular adhesion molecule-1 in paediatric connective tissue diseases
• Soluble tumour necrosis factor receptor levels reflect coagulation abnormalities in systemic juvenile chronic arthritis
• Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis
• Study of pro-inflammatory (TNF-alpha, IL-1alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters
• Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates
• Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis
• Synovial monocytes contribute to chronic inflammation in childhood-onset arthritis via IL-6/STAT signalling and cell-cell interactions
• T-cell compartment in synovial fluid of pediatric patients with JIA correlates with disease phenotype
• The decreasing prevalence of uveitis associated with juvenile rheumatoid arthritis: do NSAIDs play a role?
• Thrombocytopenia, arthritis and enteropathy: a casual association or the expression of a unique entity?
• Tumour necrosis factor alpha and its soluble receptors in juvenile chronic arthritis
• Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjogren's syndrome
• Use of recombinant interferon gamma in pediatric patients with advanced juvenile chronic arthritis
• Uveitis and juvenile idiopathic arthritis: A cohort study
• Uveitis in children with human immunodeficiency virus-associated arthritis
• Uveitis in juvenile idiopathic arthritis
• Uveitis in patients with oligoarticular juvenile idiopathic arthritis and juvenile spondyloarthritis/enthesitis related arthritis: is there any difference?